Clinical efficacy and safety of apatinib in patients with advanced colorectal cancer as the late-line treatment

AbstractThere is currently no standard therapeutic regimen available for patients with advanced colorectal cancer in whom the disease continues to progress after 2 or more lines of chemotherapy. The purpose of this study is to investigate the efficacy and safety of apatinib in patients with advanced